We have received text from S. 4491: Biodefense Diplomacy Enhancement Act. This bill was received on 2026-05-12, and currently has 1 cosponsor.
Here is a short summary of the bill:
The Biodefense Diplomacy Enhancement Act aims to improve international collaboration in biodefense, biosecurity, and biotechnology among the United States and its allies. The key components of the bill include:
Enhancement of Diplomatic Engagement
The Secretary of State is tasked with advancing U.S. foreign policy to boost cooperation in biodefense and biosecurity with allies. This involves a range of activities designed to enhance collaboration in facing biological threats and ensuring the safety of biotechnology developments.
Policy Development
The Secretary of State will coordinate with various officials to promote biodefense policy within NATO, including:
- Advocating for prioritized policy development regarding biodefense, biotechnology, and biosurveillance.
- Evaluating opportunities to strengthen NATO's biodefense capabilities.
- Proposing amendments to NATO's policies on biological threats.
- Coordinating with other NATO members on implementing biological safety measures.
- Enhancing the capabilities of NATO forces to respond to biological attacks.
- Identifying opportunities for improving NATO’s biotechnology research and deployment.
- Promoting compliance with high safety and security standards in biological research by NATO members.
Cooperation with Allies
The Secretary of State is also responsible for initiating international cooperation in biotechnology and biosecurity with non-NATO allies. This cooperation includes:
- Identifying areas of collaboration with major non-NATO allies.
- Working with allied nations to create export control policies focused on biotechnological items that pose national security risks.
- Encouraging allies to follow high safety and security standards in biological research.
- Collaborating on global enforcement of the Biological Weapons Convention.
Development of Strategies
Two significant strategies will be developed:
- NATO Biodefense Strategy: This strategy assesses current cooperation with NATO in biodefense and biotechnology, identifies planning gaps, and makes recommendations for improvements in coordination and capability development.
- International Biotechnology, Biosecurity, and Biodefense Cooperation Strategy: This outlines proposals for enhancing cooperation with allies on security matters involving biotechnology and assesses the effectiveness of export control initiatives related to high-risk biological items.
Reporting and Briefing Requirements
The Secretary of State must submit a report on the developed strategies to congressional committees within 270 days of the law's enactment. An unclassified report is required, although a classified annex may be included if necessary. Additionally, a briefing will be provided to Congress regarding significant developments related to biotechnology and biosecurity within 90 days after the enactment.
Definitions
The bill outlines key definitions to clarify terms used within, including:
- Biodefense: Actions to counter biological threats and prepare for incidents.
- Biosecurity: Policies and practices to prevent the misuse of biological materials.
- Biosurveillance: Processes for early detection of biological threats.
- Biotechnology: Using biological processes for various purposes, including research and medical use.
Relevant Companies
None found.
Senator Tim Sheehy Bill Proposals
Here are some bills which have recently been proposed by Senator Tim Sheehy:
- S.4491: Biodefense Diplomacy Enhancement Act
- S.4473: China-Africa Mining Transparency Act
- S.4304: TRAVEL Act of 2026
- S.4274: WINGS Act
- S.4256: Airmen Certificate Accessibility Act
- S.4220: Veterans Health Administration Novel Therapeutics Preparedness Act
You can track bills proposed by Senator Tim Sheehy on Quiver Quantitative's politician page for Sheehy.
Senator Tim Sheehy Net Worth
Quiver Quantitative estimates that Senator Tim Sheehy is worth $152.1M, as of May 19th, 2026. This is the 12th highest net worth in Congress, per our live estimates.
Sheehy has approximately $20.3M invested in publicly traded assets which Quiver is able to track live.
You can track Senator Tim Sheehy's net worth on Quiver Quantitative's politician page for Sheehy.
2030 Montana US Senate Election
There has been approximately $399,487,444 of spending in Montana US Senate elections over the last two years, per our estimates.
Approximately $300,795,900 of this has been from outside spending by PACs and Super PACs. Some of the groups who are spending money in this race include:
- LAST BEST PLACE PAC ($58,607,795)
- WINSENATE ($47,002,624)
- SENATE LEADERSHIP FUND ($46,590,372)
- AMERICAN CROSSROADS ($40,230,069)
- MORE JOBS, LESS GOVERNMENT ($27,496,141)
The rating for this race is currently "Solid R".
You can track this election on our matchup page for the 2030 Montana US Senate election.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
